50
Participants
Start Date
October 31, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
July 31, 2011
tivozanib
1 x 1.5 mg capsule of tivozanib orally once daily for 21 days
TGEN Clinical Research Service at Scottsdale Healthcare, Scottsdale
Florida Cancer Specialists, Fort Myers
Horizon Oncology Research, Inc., Lafayette
Jayne Gurtler MD, Laura Brinz MD, Angelo Russo MD and Janet Burroff MD APMC, Metairie
Associates in Oncology/Hematology, Rockville
Oklahoma University Cancer Institute (OUCI), Oklahoma City
Tennessee Onocology, Nashville
Multicare Research Institute/Tacoma General Hospital, Tacoma
Lead Sponsor
AVEO Pharmaceuticals, Inc.
INDUSTRY